首页> 美国卫生研究院文献>Journal of Multidisciplinary Healthcare >Postherpetic neuralgia: epidemiology pathophysiology and pain management pharmacology
【2h】

Postherpetic neuralgia: epidemiology pathophysiology and pain management pharmacology

机译:带状疱疹后神经痛:流行病学病理生理学和疼痛控制药理学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Herpes zoster, also known as shingles, is a distinctive clinical condition caused by the reactivation of latent varicella zoster (chickenpox) virus following an initial infection. Approximately 1 million cases of herpes zoster occur annually in the US, and one in every three people develops herpes zoster during their lifetime. Postherpetic neuralgia is a neuropathic pain syndrome characterized by pain that persists for months to years after resolution of the herpes zoster rash. It stems from damage to peripheral and central neurons that may be a byproduct of the immune/inflammatory response accompanying varicella zoster virus reactivation. Patients with postherpetic neuralgia report decreased quality of life and interference with activities of daily living. Approaches to management of postherpetic neuralgia include preventing herpes zoster through vaccination and/or antiviral treatment, and administering specific medications to treat pain. Current guidelines recommend treatment of postherpetic neuralgia in a hierarchical manner, with calcium channel α2-δ ligands (gabapentin and pregabalin), tricyclic antidepressants (amitriptyline, nortriptyline, or desipramine), or topical lidocaine patches as first-line drugs. The safety and tolerability of pharmacologic therapies for pain are important issues to consider as postherpetic neuralgia affects primarily an older population. Patients should be educated on appropriate dosing, titration if applicable, the importance of adherence to treatment for optimal effectiveness, and possible side effects. Health-care professionals play a key role in helping to ameliorate the pain caused by postherpetic neuralgia through early recognition and diligent assessment of the problem; recommending evidence-based treatments; and monitoring treatment adherence, adverse events, responses, and expectations. Nurse practitioners are especially crucial in establishing communication with patients and encouraging the initiation of appropriate pain-relieving treatments.
机译:带状疱疹,也称为带状疱疹,是由初始感染后潜伏的水痘带状疱疹(水痘)病毒重新激活引起的独特临床症状。在美国,每年约有一百万例带状疱疹病例,每三人中就有一个在其一生中患上带状疱疹。带状疱疹后神经痛是一种神经性疼痛综合征,其特征在于疼痛在带状疱疹消失后持续数月至数年。它源于对周围和中枢神经元的损害,这可能是水痘带状疱疹病毒再激活后免疫/炎症反应的副产物。带状疱疹后神经痛患者报告生活质量下降并干扰日常生活活动。带状疱疹后神经痛的治疗方法包括通过疫苗接种和/或抗病毒治疗预防带状疱疹,并给予治疗疼痛的特定药物。目前的指南建议采用钙通道α2-δ配体(加巴喷丁和普瑞巴林),三环抗抑郁药(阿米替林,去甲替林或去甲丙胺)或局部利多卡因贴剂作为一线药物,以分级方式治疗带状疱疹后神经痛。药物治疗疼痛的安全性和耐受性是需要考虑的重要问题,因为带状疱疹后神经痛主要影响老年人群。应该对患者进行适当剂量,滴定(如果适用),坚持治疗以取得最佳疗效的重要性以及可能的副作用的教育。卫生保健专业人员在尽早发现和认真评估该问题方面,在缓解带状疱疹后神经痛引起的疼痛方面起着关键作用;推荐循证治疗;并监控治疗依从性,不良事件,反应和期望。护士从业人员在与患者建立联系并鼓励开始适当的止痛治疗方面尤其重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号